The Efficacy and Safety of Neoadjuvant Therapy With Iparomlimab and Tuvonralimab in Locally Advanced MSI-H/dMMR Colorectal Cancer: An Prospective, Single-Arm Study (Neo-IT)

Clinical trial NCT07160647 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07160647
Sponsor: Sir Run Run Shaw Hospital
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

dMMR/MSI-H-type Rectal Adenocarcinoma

Start date: 2025-08-20
Primary completion: 2027-08-30
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.